Nurse Practitioner in Eddystone, PA Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Ms. Susan Barb, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1401 Chester Pike, Suite B, Eddystone, PA 19022 Phone: 610-447-0609 Fax: 610-649-4421 |
Ms. Catherine Marie Mcelroy, CRNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1401 Chester Pike, Eddystone, PA 19022 Phone: 610-447-0609 Fax: 610-447-1481 |
News Archive
SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses
Researchers from the US recently reported the preclinical development of a self-amplifying mRNA (SAM) vaccine that encodes a prefusion-stabilized SARS-CoV-2 spike glycoprotein.
Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer
AstraZeneca (NYSE: AZN) today announced that data from a Phase III study of postmenopausal women with hormone receptor-positive advanced breast cancer presented at the San Antonio Breast Cancer Symposium (Abstract 25) showed treatment with fulvestrant (FASLODEX) 500 mg reduced the risk of disease progression (assessed as time to progression (TTP)) by 20%
Study examines mRNA COVID-19 vaccine's effectiveness across age and gender
The findings reveal that although the two-dose vaccine regimen initially induces robust antibody response in all age groups, older male individuals are particularly associated with a gradual decline in vaccine-induced immunity six weeks after the second vaccine dose.
Study provides mechanistic insight into effects of regular coffee drinking on the brain's network
A new study published in Molecular Psychiatry and sponsored by the Institute for Scientific Information on Coffee (ISIC), provides unique insights into the functional and connectivity changes that happen within the brain of regular coffee drinkers.
Antibody therapy found effective in subgroup of patients with treatment-resistant COPD
An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.
› Verified 2 days ago